tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jiangsu Hengrui Pharmaceuticals’ Drugs Added to National Reimbursement List
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals’ Drugs Added to National Reimbursement List
1M ago
Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President
1M ago
Jiangsu Hengrui Pharmaceuticals Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Reports Strong Q3 2025 Financial Results
3M ago
Positive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
PremiumRatingsPositive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
4M ago
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
4M ago
Jiangsu Hengrui’s Innovative Drug Receives Conditional Approval
Premium
Company Announcements
Jiangsu Hengrui’s Innovative Drug Receives Conditional Approval
4M ago
Jiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
5M ago
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
5M ago
Jiangsu Hengrui Pharmaceuticals Partners with GSK for Global Licensing Agreement
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Partners with GSK for Global Licensing Agreement
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100